Clinical Trial Update: Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-remitting Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 extension study evaluates two doses of Betaseron (interferon beta-1b) for safety and tolerability in relapsing-remitting multiple sclerosis; results h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Betaseron (Interferon beta-1b)

Snippet

Sponsor: Bayer | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 2 | Status: COMPLETED | Results posted: 2009-07-03